Osaka, Japan

Motoyoshi Inooka

This inventor holds 1 USPTO granted patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoyoshi Inooka. Retrieved from https://idiyas.com/inventor/motoyoshi-inooka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Motoyoshi Inooka: Innovator in Eye Drop Composition

Introduction

Motoyoshi Inooka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of eye drop compositions. His innovative approach combines various chemical components to enhance the effectiveness of eye drops.

Latest Patents

Inooka holds a patent for an eye drop composition that includes a carboxyvinyl polymer and a monoterpene. This composition is designed to have a viscosity ranging from 200 to 100,000 mPa·s. The monoterpene can be selected from menthol, camphor, and borneol. The carboxyvinyl polymer content in the eye drop composition may range from 0.001 to 10 w/v % of the total volume, while the monoterpene content may vary from 0.0001 to 1 w/v %.

Career Highlights

Motoyoshi Inooka is associated with Rohto Pharmaceutical Co., Ltd., where he has been instrumental in advancing eye care solutions. His work has led to the development of innovative products that improve patient comfort and efficacy.

Collaborations

Inooka has collaborated with notable colleagues such as Teiko Akagi and Takayuki Miyano. Their combined expertise has contributed to the successful development of new pharmaceutical formulations.

Conclusion

Motoyoshi Inooka's contributions to the field of eye drop compositions highlight his innovative spirit and dedication to improving healthcare solutions. His patent reflects a significant advancement in the formulation of eye care products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…